{"id":7541,"date":"2025-06-17T06:30:00","date_gmt":"2025-06-17T06:30:00","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/realheart-erhaller-patentgodkannande-i-usa\/"},"modified":"2025-06-17T06:30:00","modified_gmt":"2025-06-17T06:30:00","slug":"realheart-erhaller-patentgodkannande-i-usa","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/realheart-erhaller-patentgodkannande-i-usa\/","title":{"rendered":"Realheart erh\u00e5ller patentgodk\u00e4nnande i USA"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>V\u00e4ster\u00e5s, Sverige, 17 juni 2025 &#8211; Scandinavian Real Heart AB (publ) meddelar idag att bolaget har beviljats patentgodk\u00e4nnande av United States Patent and Trademark Office (USPTO) avseende k\u00e4rnteknologin i Realheart\u00ae TAH. Samma patent har tidigare godk\u00e4nts av det europeiska patentverket (EPO).<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Det nyligen godk\u00e4nda patentet (US patent no. 12318603 B2) omfattar nyckelteknologin i Realheart\u00ae TAH, det enda artificiella hj\u00e4rtat med fyra kammare som efterliknar fysiologin i det naturliga m\u00e4nskliga hj\u00e4rtat. Dessa unika produktegenskaper ger helt nya m\u00f6jligheter att r\u00e4dda liv och ge patienterna en god livskvalitet i v\u00e4ntan p\u00e5 en hj\u00e4rttransplantation. Den strukturella utformningen kan ge viktiga f\u00f6rdelar, t.ex. minskad risk f\u00f6r stroke, bl\u00f6dning och blodbrist &#8211; vanliga biverkningar vid behandling med idag godk\u00e4nda konstgjorda hj\u00e4rtan.<\/p>\n<p>Patentgodk\u00e4nnandet ger marknadsskydd f\u00f6r enheten i USA fram till 2037.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-ddde9c982a0b\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r mer information, kontakta:<\/strong><br \/>Ina Laura Perkins, VD<br \/>Tel: +46 (0) 70 406 49 21<br \/>E-post: <a href=\"mailto:inalaura.perkins@realheart.se\" rel=\"noopener\" target=\"_blank\">inalaura.perkins@realheart.se<\/a><br \/>Certified Adviser: Svensk Kapitalmarknadsgranskning AB, <a href=\"http:\/\/www.skmg.se\" rel=\"noopener\" target=\"_blank\">www.skmg.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-0285b54ad9f5\">\n<p><strong class=\"mfn-heading-1\">Om oss<\/strong><br \/>Scandinavian Real Heart AB (publ) utvecklar det f\u00f6rsta konstgjorda hj\u00e4rtat som efterliknar det m\u00e4nskliga hj\u00e4rtats form, funktion och blodfl\u00f6desm\u00f6nster. Dessa unika produktegenskaper ger helt nya m\u00f6jligheter att r\u00e4dda liv och ge patienter en god livskvalitet i v\u00e4ntan p\u00e5 en hj\u00e4rttransplantation. I framtiden kan konstgjorda hj\u00e4rtan ocks\u00e5 bli ett alternativ till transplantation f\u00f6r bredare grupper av patienter med sv\u00e5r hj\u00e4rtsvikt. Realheart\u00ae TAH (Total Artificial Heart) utv\u00e4rderas nu i omfattande prekliniska studier inf\u00f6r en f\u00f6rsta klinisk studie p\u00e5 patienter. Bolagets aktier \u00e4r upptagna till handel p\u00e5 Nasdaq Stockholm First North Growth Market. F\u00f6r mer information, bes\u00f6k <a href=\"https:\/\/realheart.se\/sv\/\" rel=\"noopener\" target=\"_blank\">https:\/\/realheart.se\/sv\/<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><br \/><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/cc633892-f960-4acb-8b87-37d48730dc96\/realheart-erhaller-patentgodkannande-i-usa.pdf\" rel=\"noopener\" target=\"_blank\">Realheart erh\u00e5ller patentgodk\u00e4nnande i USA<\/a><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/cc633892-f960-4acb-8b87-37d48730dc96\/realheart-erhaller-patentgodkannande-i-usa.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/cc633892-f960-4acb-8b87-37d48730dc96\/realheart-erhaller-patentgodkannande-i-usa.pdf?type=jpg\"><\/span>Realheart erh\u00e5ller patentgodk\u00e4nnande i USA<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>V\u00e4ster\u00e5s, Sverige, 17 juni 2025 &#8211; Scandinavian Real Heart AB (publ) meddelar idag att bolaget har beviljats patentgodk\u00e4nnande av United States Patent and Trademark Office (USPTO) avseende k\u00e4rnteknologin i Realheart\u00ae TAH. Samma patent har tidigare godk\u00e4nts av det europeiska patentverket (EPO). Det nyligen godk\u00e4nda patentet (US patent no. 12318603 B2) omfattar nyckelteknologin i Realheart\u00ae TAH,&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-7541","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-ext-nq","mfn-news-tag-mfn-ext-nq-company-announcement","mfn-news-tag-mfn","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn-lang-sv"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Realheart erh\u00e5ller patentgodk\u00e4nnande i USA - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/mfn_news\/realheart-erhaller-patentgodkannande-i-usa\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Realheart erh\u00e5ller patentgodk\u00e4nnande i USA - Realheart\" \/>\n<meta property=\"og:description\" content=\"V\u00e4ster\u00e5s, Sverige, 17 juni 2025 &#8211; Scandinavian Real Heart AB (publ) meddelar idag att bolaget har beviljats patentgodk\u00e4nnande av United States Patent and Trademark Office (USPTO) avseende k\u00e4rnteknologin i Realheart\u00ae TAH. Samma patent har tidigare godk\u00e4nts av det europeiska patentverket (EPO). Det nyligen godk\u00e4nda patentet (US patent no. 12318603 B2) omfattar nyckelteknologin i Realheart\u00ae TAH,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/mfn_news\/realheart-erhaller-patentgodkannande-i-usa\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-erhaller-patentgodkannande-i-usa\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-erhaller-patentgodkannande-i-usa\\\/\",\"name\":\"Realheart erh\u00e5ller patentgodk\u00e4nnande i USA - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"datePublished\":\"2025-06-17T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-erhaller-patentgodkannande-i-usa\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-erhaller-patentgodkannande-i-usa\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-erhaller-patentgodkannande-i-usa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Realheart erh\u00e5ller patentgodk\u00e4nnande i USA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Realheart erh\u00e5ller patentgodk\u00e4nnande i USA - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/mfn_news\/realheart-erhaller-patentgodkannande-i-usa\/","og_locale":"sv_SE","og_type":"article","og_title":"Realheart erh\u00e5ller patentgodk\u00e4nnande i USA - Realheart","og_description":"V\u00e4ster\u00e5s, Sverige, 17 juni 2025 &#8211; Scandinavian Real Heart AB (publ) meddelar idag att bolaget har beviljats patentgodk\u00e4nnande av United States Patent and Trademark Office (USPTO) avseende k\u00e4rnteknologin i Realheart\u00ae TAH. Samma patent har tidigare godk\u00e4nts av det europeiska patentverket (EPO). Det nyligen godk\u00e4nda patentet (US patent no. 12318603 B2) omfattar nyckelteknologin i Realheart\u00ae TAH,...","og_url":"https:\/\/realheart.se\/mfn_news\/realheart-erhaller-patentgodkannande-i-usa\/","og_site_name":"Realheart","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/mfn_news\/realheart-erhaller-patentgodkannande-i-usa\/","url":"https:\/\/realheart.se\/mfn_news\/realheart-erhaller-patentgodkannande-i-usa\/","name":"Realheart erh\u00e5ller patentgodk\u00e4nnande i USA - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"datePublished":"2025-06-17T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/realheart.se\/mfn_news\/realheart-erhaller-patentgodkannande-i-usa\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/mfn_news\/realheart-erhaller-patentgodkannande-i-usa\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/mfn_news\/realheart-erhaller-patentgodkannande-i-usa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"MFN News Items","item":"https:\/\/realheart.se\/mfn_news\/"},{"@type":"ListItem","position":2,"name":"Realheart erh\u00e5ller patentgodk\u00e4nnande i USA"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news\/7541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=7541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}